Harnessing Peptide-Based Targeted Protein Degradation to Unlock Previously Undruggable Targets
11:30 am - Wednesday 2nd December 2026
- Explore how cyclic peptide-based degraders are expanding the therapeutic landscape by enabling the selective degradation of disease-driving proteins beyond the reach of conventional small molecules.
- Understand the key design principles for engineering peptide degraders with improved target specificity, intracellular activity, and therapeutic potential.
- Discover emerging opportunities and translational challenges in applying peptide-based targeted protein degradation across oncology and other high-value therapeutic areas.
